- Data-driven intelligence helps businesses thrive, http://ow.ly/1dRVZ #
- New vaccine could slow Parkinson's disease progression in humans, http://ow.ly/1dhVH #
- Celsion will begin Phase II trial of ThermoDox later this year, http://ow.ly/1dhYV #
- Ariad's blood cancer drug gains FDA orphan-drug status, http://ow.ly/1di0U #
- Farmers seek injunction on use of biotech sugar beets, http://ow.ly/1di68 #
- Google sparks new wave of innovation, http://ow.ly/1di8R #
- Face-to-face marketing matters more than ever, http://ow.ly/1dqpK #
- Stem Cell Innovations obtains research contract from German firm Agennix, http://ow.ly/1dRND #
- Synta gets FDA clearance to resume work on skin cancer drug, http://ow.ly/1dRQa #
- RT @davidgerzof: How much are social media platforms worth? FB $11.5B, Twitter $1.4B, LinkedIn $1.3B, 2nd Life $383M, http://bit.ly/bVil57 #
- Merck KGaA plans to move U.S. chemical unit to Massachusetts, http://ow.ly/1ekFb #
- Stemgent invests $4.5M in Scotland-based startup firm, http://ow.ly/1el1V #
- Report: Iceland is more creative than America, http://ow.ly/1embS #
